Expansion of regulatory T cells by CD28 superagonistic antibodies attenuates neurodegeneration in A53T-α-synuclein Parkinson’s disease mice
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-2094
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Expansion of regulatory T cells by CD28 superagonistic antibodies attenuates neurodegeneration in A53T-α-synuclein Parkinson’s disease mice ; volume:19 ; number:1 ; day:31 ; month:12 ; year:2022 ; pages:1-19 ; date:12.2022
Journal of neuroinflammation ; 19, Heft 1 (31.12.2022), 1-19, 12.2022
- Creator
-
Badr, Mohammad
McFleder, Rhonda L.
Wu, Jingjing
Knorr, Susanne
Koprich, James B.
Hünig, Thomas
Brotchie, Jonathan M.
Volkmann, Jens
Lutz, Manfred B.
Ip, Chi Wang
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12974-022-02685-7
- URN
-
urn:nbn:de:101:1-2023031109234463610228
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Badr, Mohammad
- McFleder, Rhonda L.
- Wu, Jingjing
- Knorr, Susanne
- Koprich, James B.
- Hünig, Thomas
- Brotchie, Jonathan M.
- Volkmann, Jens
- Lutz, Manfred B.
- Ip, Chi Wang
- SpringerLink (Online service)
Other Objects (12)
Targeting Regulatory T Cells by CD28 Superagonistic Antibodies Mitigates Neurodegeneration in the A53T-alpha-Synuclein Parkinson’s Disease Mouse Model
Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson’s disease
Neurodegeneration by α-synuclein-specific T cells in AAV-A53T-α-synuclein Parkinson’s disease mice
Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease
Microglial inhibition alleviates alpha-synuclein propagation and neurodegeneration in Parkinson’s disease mouse model
Alpha-synuclein-induced stress sensitivity renders the Parkinson’s disease brain susceptible to neurodegeneration
Systemic inflammation accelerates neurodegeneration in a rat model of Parkinson’s disease overexpressing human alpha synuclein
Alpha Synuclein Specific T Lymphocytes Promote Neurodegeneration in the A53T-α-synuclein Parkinson's Disease Mouse Model
VPS35 and α-Synuclein fail to interact to modulate neurodegeneration in rodent models of Parkinson’s disease
Alpha-synuclein in Parkinson’s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction
Transmission of alpha-synuclein in Parkinson’s disease
Astrocytic expression of Parkinson's disease-related A53T α-synuclein causes neurodegeneration in mice
Targeting Regulatory T Cells by CD28 Superagonistic Antibodies Mitigates Neurodegeneration in the A53T-alpha-Synuclein Parkinson’s Disease Mouse Model
Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson’s disease
Neurodegeneration by α-synuclein-specific T cells in AAV-A53T-α-synuclein Parkinson’s disease mice
Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease
Microglial inhibition alleviates alpha-synuclein propagation and neurodegeneration in Parkinson’s disease mouse model
Alpha-synuclein-induced stress sensitivity renders the Parkinson’s disease brain susceptible to neurodegeneration
Systemic inflammation accelerates neurodegeneration in a rat model of Parkinson’s disease overexpressing human alpha synuclein
Alpha Synuclein Specific T Lymphocytes Promote Neurodegeneration in the A53T-α-synuclein Parkinson's Disease Mouse Model
VPS35 and α-Synuclein fail to interact to modulate neurodegeneration in rodent models of Parkinson’s disease
Alpha-synuclein in Parkinson’s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction
Transmission of alpha-synuclein in Parkinson’s disease
Astrocytic expression of Parkinson's disease-related A53T α-synuclein causes neurodegeneration in mice
Targeting Regulatory T Cells by CD28 Superagonistic Antibodies Mitigates Neurodegeneration in the A53T-alpha-Synuclein Parkinson’s Disease Mouse Model
Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson’s disease
Neurodegeneration by α-synuclein-specific T cells in AAV-A53T-α-synuclein Parkinson’s disease mice
Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease
Microglial inhibition alleviates alpha-synuclein propagation and neurodegeneration in Parkinson’s disease mouse model
Alpha-synuclein-induced stress sensitivity renders the Parkinson’s disease brain susceptible to neurodegeneration
Systemic inflammation accelerates neurodegeneration in a rat model of Parkinson’s disease overexpressing human alpha synuclein
Alpha Synuclein Specific T Lymphocytes Promote Neurodegeneration in the A53T-α-synuclein Parkinson's Disease Mouse Model
VPS35 and α-Synuclein fail to interact to modulate neurodegeneration in rodent models of Parkinson’s disease
Alpha-synuclein in Parkinson’s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction
Transmission of alpha-synuclein in Parkinson’s disease